[Lipoatrophic diabetes. A case description].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D001284:Atrophy / Q000175:diagnosis* / Q000188:drug therapy; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000188:drug therapy; D005132:Eye Manifestations; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008060:Lipodystrophy / Q000175:diagnosis*; D008797:Metyrapone / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D006854:Hydrocortisone; D008797:Metyrapone
Lipatrofichen diabet. Opisanie na sluchai.